Stock listing
CBLL Stock Price, News, Filings & Events — Ceribell, Inc.
Selected listing: CBLL · NASDAQ · USD · US
This page tracks Ceribell, Inc.'s CBLL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CBLL:NASDAQ. CBLL:NASDAQ is the stock-level entry point for investors researching Ceribell, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ceribell, Inc. (Ticker: CBLL) is a public company based in the United States, with a market capitalization of approximately $641.6 million. The company focuses on innovative solutions in its industry, aiming to enhance patient care and outcomes. Ceribell is committed to advancing technology and improving the healthcare landscape.
- Ticker
- CBLL:NASDAQ
- Asset type
- Stock
- Market cap
- $910.7M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Ceribell, Inc. CBLL:NASDAQ stock context
This page tracks Ceribell, Inc.'s CBLL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CBLL:NASDAQ. CBLL:NASDAQ is the stock-level entry point for investors researching Ceribell, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ceribell, Inc. (Ticker: CBLL) is a public company based in the United States, with a market capitalization of approximately $641.6 million. The company focuses on innovative solutions in its industry, aiming to enhance patient care and outcomes. Ceribell is committed to advancing technology and improving the healthcare landscape.
Latest news from Ceribell, Inc.
Ceribell Reports Second Quarter 2026 Financial Results
August 10, 2026
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
August 3, 2026
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
July 29, 2026
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
July 20, 2026
Ceribell, Inc. earnings calls
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call
August 10, 2026 · Replay with transcript and chapters
CeriBell, Inc. (CBLL) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
CeriBell, Inc. (CBLL) Q4 2025 Earnings Call
February 24, 2026 · Replay with transcript and chapters
CeriBell, Inc. (CBLL) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
CeriBell, Inc. (CBLL) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
CeriBell, Inc. (CBLL) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Ceribell, Inc.
Ceribell, Inc. investor report
Review AI stock analysis and investor report context for CBLL:NASDAQ.
Ceribell, Inc. company profile
View the public company page for Ceribell, Inc. on 6ix.
Ceribell, Inc. news
Read company news and market updates connected to Ceribell, Inc..
Ceribell, Inc. investor events
Find investor webinars, events, and replay context for Ceribell, Inc..